Rajeev Indrajit Desai, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Nicotine | 10 | 2024 | 680 | 3.000 |
Why?
|
Space Flight | 4 | 2024 | 219 | 2.160 |
Why?
|
Behavior, Animal | 8 | 2018 | 1862 | 1.740 |
Why?
|
Nicotinic Agonists | 6 | 2020 | 265 | 1.700 |
Why?
|
Cocaine | 14 | 2017 | 947 | 1.480 |
Why?
|
Saimiri | 7 | 2024 | 337 | 1.470 |
Why?
|
Weightlessness | 2 | 2022 | 103 | 1.440 |
Why?
|
Cannabinoids | 2 | 2023 | 174 | 1.430 |
Why?
|
Alkaloids | 3 | 2024 | 192 | 1.420 |
Why?
|
Dopamine Uptake Inhibitors | 9 | 2017 | 287 | 1.050 |
Why?
|
Racemases and Epimerases | 2 | 2024 | 113 | 1.040 |
Why?
|
Benztropine | 4 | 2017 | 17 | 0.990 |
Why?
|
Self Administration | 3 | 2024 | 386 | 0.990 |
Why?
|
Receptors, Dopamine D1 | 4 | 2007 | 277 | 0.930 |
Why?
|
Dopamine Agonists | 5 | 2010 | 347 | 0.930 |
Why?
|
Cosmic Radiation | 1 | 2023 | 24 | 0.880 |
Why?
|
Receptors, Nicotinic | 2 | 2018 | 494 | 0.830 |
Why?
|
Methamphetamine | 3 | 2014 | 167 | 0.770 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 2 | 2024 | 903 | 0.750 |
Why?
|
Dose-Response Relationship, Drug | 19 | 2024 | 10763 | 0.740 |
Why?
|
Nicotinic Antagonists | 3 | 2018 | 94 | 0.730 |
Why?
|
Behavior, Addictive | 2 | 2016 | 428 | 0.720 |
Why?
|
Central Nervous System Stimulants | 5 | 2014 | 1168 | 0.610 |
Why?
|
Tobacco Use Disorder | 3 | 2024 | 708 | 0.610 |
Why?
|
Astronauts | 3 | 2024 | 94 | 0.590 |
Why?
|
Receptor, Cannabinoid, CB1 | 2 | 2023 | 137 | 0.590 |
Why?
|
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | 3 | 2006 | 50 | 0.560 |
Why?
|
Vaccines | 2 | 2016 | 843 | 0.540 |
Why?
|
Motor Activity | 7 | 2013 | 2711 | 0.530 |
Why?
|
Fentanyl | 3 | 2023 | 451 | 0.500 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 4 | 2013 | 417 | 0.500 |
Why?
|
Conditioning, Operant | 5 | 2024 | 308 | 0.500 |
Why?
|
Dopamine Agents | 2 | 2014 | 188 | 0.490 |
Why?
|
Benzazepines | 5 | 2010 | 308 | 0.490 |
Why?
|
Respiratory Insufficiency | 1 | 2023 | 1240 | 0.480 |
Why?
|
Smoke | 1 | 2016 | 242 | 0.450 |
Why?
|
Substance Withdrawal Syndrome | 2 | 2020 | 628 | 0.420 |
Why?
|
Rats | 14 | 2023 | 23782 | 0.390 |
Why?
|
Mice, Knockout | 4 | 2024 | 14488 | 0.380 |
Why?
|
Dopamine | 5 | 2018 | 1592 | 0.370 |
Why?
|
Animals | 32 | 2024 | 169285 | 0.360 |
Why?
|
Immunization | 1 | 2015 | 1219 | 0.360 |
Why?
|
Cholinergic Agents | 1 | 2010 | 97 | 0.350 |
Why?
|
Biogenic Monoamines | 1 | 2010 | 50 | 0.340 |
Why?
|
Blinking | 2 | 2007 | 135 | 0.340 |
Why?
|
Nanotechnology | 1 | 2016 | 714 | 0.340 |
Why?
|
Discrimination Learning | 6 | 2015 | 278 | 0.300 |
Why?
|
Schizophrenia | 2 | 2024 | 6983 | 0.290 |
Why?
|
Drug Interactions | 4 | 2018 | 1419 | 0.280 |
Why?
|
Immunologic Factors | 1 | 2015 | 1596 | 0.250 |
Why?
|
Drug Delivery Systems | 1 | 2016 | 2237 | 0.230 |
Why?
|
Atropine Derivatives | 1 | 2023 | 5 | 0.230 |
Why?
|
Generalization, Stimulus | 2 | 2003 | 13 | 0.230 |
Why?
|
Drug Inverse Agonism | 1 | 2023 | 11 | 0.230 |
Why?
|
Smoking Cessation | 1 | 2016 | 2085 | 0.220 |
Why?
|
Nucleus Accumbens | 3 | 2018 | 358 | 0.220 |
Why?
|
Aerospace Medicine | 1 | 2024 | 95 | 0.220 |
Why?
|
Rats, Sprague-Dawley | 9 | 2017 | 8142 | 0.210 |
Why?
|
Cholinergic Agonists | 1 | 2003 | 75 | 0.210 |
Why?
|
Heroin | 1 | 2022 | 120 | 0.190 |
Why?
|
Male | 27 | 2024 | 364731 | 0.190 |
Why?
|
Oxycodone | 1 | 2022 | 144 | 0.180 |
Why?
|
Piperazines | 3 | 2017 | 2554 | 0.170 |
Why?
|
Naltrexone | 1 | 2022 | 319 | 0.170 |
Why?
|
Ligands | 3 | 2013 | 3284 | 0.170 |
Why?
|
Mice | 10 | 2024 | 82049 | 0.170 |
Why?
|
Eating | 2 | 2017 | 1542 | 0.170 |
Why?
|
Reinforcement Schedule | 3 | 2017 | 123 | 0.160 |
Why?
|
Membrane Transport Proteins | 1 | 2005 | 1037 | 0.160 |
Why?
|
Primates | 1 | 2021 | 520 | 0.150 |
Why?
|
Self Stimulation | 1 | 2017 | 46 | 0.150 |
Why?
|
Mecamylamine | 2 | 2010 | 27 | 0.150 |
Why?
|
Narcotic Antagonists | 1 | 2022 | 591 | 0.140 |
Why?
|
Cognition | 3 | 2024 | 7073 | 0.140 |
Why?
|
Excitatory Amino Acid Transporter 2 | 1 | 2018 | 89 | 0.140 |
Why?
|
Drug Tolerance | 2 | 2012 | 365 | 0.140 |
Why?
|
Analgesics, Opioid | 2 | 2023 | 3837 | 0.140 |
Why?
|
Amphetamine | 1 | 2018 | 222 | 0.140 |
Why?
|
Anabasine | 1 | 2016 | 6 | 0.130 |
Why?
|
Locomotion | 1 | 2018 | 388 | 0.120 |
Why?
|
Cotinine | 1 | 2016 | 206 | 0.120 |
Why?
|
Sleep Deprivation | 1 | 2022 | 848 | 0.120 |
Why?
|
Berberine | 1 | 2015 | 26 | 0.120 |
Why?
|
Microdialysis | 2 | 2017 | 156 | 0.120 |
Why?
|
Models, Animal | 1 | 2021 | 2122 | 0.120 |
Why?
|
Drug Partial Agonism | 1 | 2014 | 24 | 0.110 |
Why?
|
Fear | 2 | 2020 | 1493 | 0.110 |
Why?
|
Membrane Glycoproteins | 1 | 2005 | 3713 | 0.110 |
Why?
|
Pyridines | 2 | 2016 | 2894 | 0.110 |
Why?
|
Piperidines | 1 | 2022 | 1667 | 0.110 |
Why?
|
Protein Isoforms | 1 | 2018 | 1715 | 0.110 |
Why?
|
Dopamine Antagonists | 2 | 2005 | 284 | 0.110 |
Why?
|
Mice, Inbred C57BL | 3 | 2024 | 22380 | 0.110 |
Why?
|
Electroshock | 1 | 2012 | 120 | 0.100 |
Why?
|
Nerve Tissue Proteins | 1 | 2005 | 4413 | 0.100 |
Why?
|
Receptors, Dopamine D2 | 2 | 2003 | 471 | 0.090 |
Why?
|
Gene Deletion | 1 | 2018 | 2674 | 0.090 |
Why?
|
Pentobarbital | 1 | 2010 | 153 | 0.090 |
Why?
|
Dextroamphetamine | 1 | 2010 | 132 | 0.090 |
Why?
|
Muscarinic Antagonists | 1 | 2010 | 136 | 0.080 |
Why?
|
Stereoisomerism | 2 | 2006 | 612 | 0.080 |
Why?
|
Cholinesterase Inhibitors | 1 | 2010 | 241 | 0.080 |
Why?
|
Quinoxalines | 1 | 2010 | 297 | 0.080 |
Why?
|
Avoidance Learning | 1 | 2010 | 248 | 0.080 |
Why?
|
Extracellular Space | 1 | 2010 | 563 | 0.070 |
Why?
|
Inhibitory Concentration 50 | 2 | 2007 | 466 | 0.070 |
Why?
|
Time Perception | 1 | 2008 | 87 | 0.070 |
Why?
|
Central Nervous System Depressants | 1 | 2008 | 163 | 0.070 |
Why?
|
Tropanes | 1 | 2006 | 48 | 0.070 |
Why?
|
Antibodies, Monoclonal | 1 | 2023 | 9262 | 0.070 |
Why?
|
Analysis of Variance | 1 | 2015 | 6229 | 0.070 |
Why?
|
Photic Stimulation | 1 | 2012 | 1997 | 0.070 |
Why?
|
Methylphenidate | 1 | 2010 | 480 | 0.060 |
Why?
|
Disease Models, Animal | 1 | 2024 | 18349 | 0.060 |
Why?
|
Feeding Behavior | 1 | 2017 | 3205 | 0.060 |
Why?
|
Phosphatidylinositols | 1 | 2005 | 280 | 0.060 |
Why?
|
Hydrolysis | 1 | 2005 | 646 | 0.060 |
Why?
|
Caffeine | 1 | 2008 | 703 | 0.060 |
Why?
|
Flupenthixol | 1 | 2003 | 11 | 0.050 |
Why?
|
Quinpirole | 1 | 2003 | 27 | 0.050 |
Why?
|
Pilocarpine | 1 | 2003 | 64 | 0.050 |
Why?
|
Nanoparticles | 1 | 2015 | 1986 | 0.050 |
Why?
|
Muscarinic Agonists | 1 | 2003 | 91 | 0.050 |
Why?
|
Ethanol | 1 | 2008 | 1331 | 0.050 |
Why?
|
Humans | 8 | 2024 | 768171 | 0.050 |
Why?
|
Substance-Related Disorders | 1 | 2017 | 4423 | 0.050 |
Why?
|
Acetylcholine | 1 | 2003 | 629 | 0.050 |
Why?
|
Psychomotor Performance | 1 | 2008 | 1892 | 0.040 |
Why?
|
Pharmacogenetics | 1 | 2024 | 683 | 0.040 |
Why?
|
Protein Conformation | 1 | 2007 | 3956 | 0.040 |
Why?
|
Infusion Pumps, Implantable | 1 | 2020 | 158 | 0.040 |
Why?
|
Rats, Long-Evans | 1 | 2020 | 380 | 0.040 |
Why?
|
Time Factors | 2 | 2015 | 40220 | 0.040 |
Why?
|
Injections, Subcutaneous | 1 | 2020 | 687 | 0.040 |
Why?
|
Corpus Striatum | 1 | 2005 | 1224 | 0.040 |
Why?
|
Internationality | 1 | 2024 | 1008 | 0.040 |
Why?
|
Biological Specimen Banks | 1 | 2024 | 788 | 0.040 |
Why?
|
Neurons | 1 | 2018 | 9514 | 0.040 |
Why?
|
Injections, Intravenous | 1 | 2020 | 1379 | 0.040 |
Why?
|
Conditioning, Classical | 1 | 2020 | 368 | 0.040 |
Why?
|
Cerebellum | 1 | 2005 | 1522 | 0.040 |
Why?
|
Mice, 129 Strain | 1 | 2018 | 369 | 0.030 |
Why?
|
Monitoring, Physiologic | 1 | 2024 | 1798 | 0.030 |
Why?
|
Brain | 2 | 2022 | 27362 | 0.030 |
Why?
|
Acoustic Stimulation | 1 | 2020 | 1255 | 0.030 |
Why?
|
United States | 1 | 2023 | 73039 | 0.030 |
Why?
|
Cues | 1 | 2020 | 878 | 0.030 |
Why?
|
Light | 1 | 2020 | 1355 | 0.030 |
Why?
|
Serine | 1 | 2017 | 831 | 0.030 |
Why?
|
Synaptic Transmission | 1 | 1999 | 1177 | 0.030 |
Why?
|
Glutamic Acid | 1 | 2017 | 1191 | 0.020 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2017 | 1141 | 0.020 |
Why?
|
Interpersonal Relations | 1 | 2018 | 1434 | 0.020 |
Why?
|
Astrocytes | 1 | 2018 | 1350 | 0.020 |
Why?
|
Mesylates | 1 | 2007 | 37 | 0.020 |
Why?
|
Receptor, Muscarinic M1 | 1 | 2006 | 25 | 0.020 |
Why?
|
Norepinephrine Plasma Membrane Transport Proteins | 1 | 2006 | 66 | 0.020 |
Why?
|
Radioligand Assay | 1 | 2006 | 366 | 0.020 |
Why?
|
Female | 4 | 2018 | 397187 | 0.020 |
Why?
|
COS Cells | 1 | 2007 | 1135 | 0.020 |
Why?
|
Hand Strength | 1 | 2008 | 466 | 0.020 |
Why?
|
Hippocampus | 1 | 2018 | 3783 | 0.020 |
Why?
|
Alanine | 1 | 2007 | 614 | 0.010 |
Why?
|
Protein Binding | 2 | 2007 | 9343 | 0.010 |
Why?
|
Reading | 1 | 2008 | 543 | 0.010 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 1 | 2006 | 326 | 0.010 |
Why?
|
Amino Acid Substitution | 1 | 2007 | 1743 | 0.010 |
Why?
|
Biological Transport | 1 | 2007 | 2085 | 0.010 |
Why?
|
Comorbidity | 1 | 2017 | 10590 | 0.010 |
Why?
|
Reaction Time | 1 | 2008 | 2101 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 2006 | 3056 | 0.010 |
Why?
|
Phenotype | 1 | 2018 | 16726 | 0.010 |
Why?
|
Transfection | 1 | 2007 | 5756 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2007 | 2709 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2008 | 12466 | 0.010 |
Why?
|
Young Adult | 1 | 2008 | 60066 | 0.000 |
Why?
|
Adult | 1 | 2008 | 223646 | 0.000 |
Why?
|